Anti-angiogenic functional foods, degenerative disease and cancer

Functional Foods, Ageing and Degenerative Disease

Volumn , Issue , 2004, Pages 485-523

  Losso, J N ^a   Bansode, R R ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58149276199     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-85573-725-9.50022-8     Document Type: Chapter

References (183)

1. R AEBERSOLD and BF CRAVATT (2002) ‘Proteomics - advances, applications and the challenges that remain’. Trends Biotechnol. 20(12 Suppl), S1-S2
2. KC AGARWAL (1996) ‘Therapeutic actions of garlic constituents’. Med Res Rev. 16(1), 111-124
3. DA ALLEN, S HARWOOD, M VARAGUNAM, MJ RAFTERY and MM YAQOOB (2003) ‘High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases’. FASEB J. 17(8), 908-910
4. F AMICARELLI, AM RAGNELLI, P AIMOLA, A BONFIGLI, S COLAFARINA, C DI ILIO and M MIRANDA (1999) ‘Age-dependent ultrastructural alterations and biochemical response of rat skeletal muscle after hypoxic or hyperoxic treatments’. Biochim Biophys Acta. 1453(1), 105-114
5. O ARRIETA, P GUEVARA, S REYES, A ORTIZ, D REMBAO and J SOTELO (1998) ‘Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine’. Eur J Cancer. 34(13), 2101-2106
6. IR ASPLIN, SM WU, S MATHEW, G BHATTACHARJEE and SV PIZZO (2001) ‘Differential regulation of the fibroblast growth factor (FGF) family by alpha(2)-macroglobulin: evidence for selective modulation of FGF-2-induced angiogenesis’. Blood 97(11), 3450-3457
7. HA BAWADI, TM ANTUNES, F SHIH and JN LOSSO (2004) ‘In vitro inhibition of the activation of pro-metalloproteinase-1 (pro-MMP-1) and pro-metalloproteinase-9 (pro-MMP-9) by rice and soybean Bowman-Birk inhibitors’. J. Agric. Food Chem. In press
8. Y BEN-YOSEF, N LAHAT, S SHAPIRO, H BITTERMAN and A MILLER (2002) ‘Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation’. Circ Res. 90(7), 784-791
9. B BERRA, I COLOMBO, E SOTTOCORNOLA and A GIACOSA (2002) ‘Dietary sphingolipids in colorectal cancer prevention’. Eur J Cancer Prev. 11(2), 193-197
10. C BLAZQUEZ, ML CASANOVA, A PLANAS, TG DEL PULGAR, C VILLANUEVA, MJ FERNANDEZ-ACENERO, J ARAGONES, JW HUFFMAN, JL JORCANO and M GUZMAN (2003) ‘Inhibition of tumor angiogenesis by cannabinoids’. FASEB J. 17(3), 529-531
11. D BOIVIN, S GENDRON, E BEAULIEU, D GINGRAS and R BELIVEAU (2002) ‘The antiangiogenic agent Neovastat (AE-941) induces endothelial cell apoptosis’. Mol Cancer Ther. 1(10), 795-802
12. RT BREE, C STENSON-COX, M GREALY, L BYRNES, AM GORMAN and A SAMALI (2001) ‘Cellular longevity: role of apoptosis and replicative senescence’. Biogerontology 3(4), 195-206
13. JK BRUNELLE and NS CHANDEL (2002) ‘Oxygen deprivation induced cell death: An update’. Apoptosis 7(6), 475-482
14. A BUDA, D QUALTROUGH, MA JEPSON, D MARTINES, C PARASKEVA and M PIGNATELLI (2003) ‘Butyrate downregulates alpha2beta1 integrin: a possible role in the induction of apoptosis in colorectal cancer cell lines’. Gut. 52(5), 729-734
15. Y CAO, R CAO and E BRAKENHIELM (2002) ‘Antiangiogenic mechanisms of diet-derived polyphenols’. J. Nutr. Biochem. 13(7), 380-390
16. ML CASANOVA, C BLAZQUEZ, J MARTINEZ-PALACIO, C VILLANUEVA, MJ FERNANDEZ-ACENERO, JW HUFFMAN, JL JORCANO and M GUZMAN (2003) ‘Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors’. J Clin Invest. 111(1), 43-50
17. NS CHANDEL and PT SCHUMACKER (2000) ‘Cellular oxygen sensing by mitochondria: old questions, new insight’. J Appl Physiol. 88(5), 1880-1889
18. H CHERIF, JL TARRY, SE OZANNE and CN HALES (2003) ‘Ageing and telomeres: a study into organ- and gender-specific telomere shortening’. Nucleic Acids Res. 31(5), 1576-1583
19. T-C CHOU, E FU, C-J WU and JH YEH (2003) ‘Chitosan enhances platelet adhesion and aggregation’. Biochem Biophys Res Commun. 302(3), 480-483
20. MC CID, HW SCHNAPER and HK KLEINMAN (2002) ‘Estrogens and the vascular endothelium’. Ann NY Acad Sci. 966 143-157
21. JR CINATLJ, R KOTCHETKOV, R BLAHETA, PH DRIEVER, JU VOGEL and J CINATL (2002) ‘Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha’. Int J Oncol. 20 97-106
22. A CREMESTI, F PARIS, H GRASSME, N HOLLER, J TSCHOPP, Z FUKS, E GULBINS and R KOLESNICK (2001) ‘Ceramide enables fas to cap and kill’. J Biol Chem. 276(26), 23954-23961
23. TP DALTON, HG SHERTZER and A PUGA (1999) ‘Regulation of gene expression by reactive oxygen’. Annu Rev. Pharmacol. Toxicol. 39(1), 67-101
24. VM DIRSCH and AM VOLLMAR (2001) ‘Ajoene, a natural product with non-steroidal anti-inflammatory drug (NSAID)-like properties? Biochem Pharmacol. 61(5), 587-593
25. TA DRIXLER, MJ VOGTEN, ED RITCHIE, TJ VAN VROONHOVEN, MF GEBBINK, EE VOEST and IH BOREL RINKES (2002) ‘Liver regeneration is an angiogenesis-associated phenomenon’. Ann Surg. 236(6), 703-712
26. RD DUAN, Y CHENG, G HANSEN, E HERTERVIG, JJ LIU, I SYK, H SJOSTROM and A NILSSON (2003) ‘Purification, localization, and expression of human intestinal alkaline sphingomyelinase’. J Lipid Res. 44(6), 1241-1250
27. SE DUNN, FW KARI, J FRENCH, JR LEININGER, G TRAVLOS, R WILSON and JC BARRETT (1997) ‘Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice’. Cancer Res. 57(21), 4667-4672
28. LA ESPOSITO, JE KOKOSZKA, KG WAYMIRE, B COTTRELL, GR MACGREGOR and DC WALLACE (2000) ‘Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene’. Free Radic Biol Med. 28(5), 754-766
29. P FALARDEAU, P CHAMPAGNE, P POYET, C HARITON and E. DUPONT (2001) ‘Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials.’. Semin Oncol. 28(6), 620-625
30. L FELDMAN and C ROULEAU (2002) ‘Troponin I inhibits capillary endothelial cell proliferation by interaction with the cell's bFGF receptor’. Microvascular Res. 63(1), 41-49
31. M FISHER and LX YANG (2002) ‘Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy’. Anticancer Res. 22(3), 1737-1754
32. J. FOLKMAN (1995) ‘Angiogenesis in cancer, vascular, rheumatoid and other disease’. Nat Med. 1 27-31
33. J FOLKMAN, E MERLER, C ABERNATHY and G WILLIAMS (1971) ‘Isolation of a tumor factor responsible for angiogenesis’. J. Exp. Med. 133(2), 275-288
34. PF FOX and PLH MCSWEENEY (1998) Dairy Chemistry and Biochemistry Blackie Academic and Professional
35. LT FRAME, RW HART and JE LEAKEY (1998) ‘Caloric restriction as a mechanism mediating resistance to environmental disease’. Environ Health Perspect 106(Suppl1), 313-324
36. E FUHRMANN-BENZAKEIN, MN MA, L RUBBIA-BRANDT, G MENTHA, D RUEFENACHT, AP SAPPINO and MS PEPPER (2000) ‘Elevated levels of angiogenic cytokines in the plasma of cancer patients’. Int J Cancer. 85(1), 40-45
37. NW GALE, G THURSTON, SF HACKETT, R RENARD, Q WANG, J MCCLAIN, C MARTIN, C WITTE, MH WITTE, D JACKSON, C SURI, PA CAMPOCHIARO, SJ WIEGAND and GD YANCOPOULOS (2002) ‘Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1’. Dev Cell. 3(3), 411-423
38. SC GAUTAM, YX XU, M DUMAGUIN, N JANAKIRAMAN and RA CHAPMAN (2000) ‘Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging’. Bone Marrow Transplant 25(6), 639-645
39. HP GERBER and N FERRARA (2000) ‘Angiogenesis and bone growth’. Trends Cardiovasc Med. 10(5), 223-228
40. A GNJEC, JA FONTE, C ATWOOD and RN MARTINS (2002) ‘Transition metal chelator therapy - a potential treatment for Alzheimer's disease?’. Front Biosci. 7 1016-1023
41. CW GREIDER (1994) ‘Mammalian telomere dynamics: healing, fragmentation shortening and stabilization’. Curr Opin Genet Dev. 4(2), 203-211
42. S GRETHER-BECK, R BUETTNER and J KRUTMANN (1997) ‘Ultraviolet A radiation-induced expression of human genes: molecular and photobiological mechanisms’. Biol Chem. 378(11), 1231-1236
43. MB GRISHAM, D JOURD'HEUIL and DA WINK (2000) ‘Review article: chronic inflammation and reactive oxygen and nitrogen metabolism - implications in DNA damage and mutagenesis’. Aliment Pharmacol Ther. 14(suppl 1), 3-9
44. TL HAAS (2002) ‘Molecular control of capillary growth in skeletal muscle’. Can J Appl Physiol. 27(5), 491-515
45. RN HAN, M POST, AK TANSWELL and SJ LYE (2003) ‘Insulin-like growth factor-I receptor-mediated vasculogenesis/angiogenesis in human lung development’. Am J Respir Cell Mol Biol. 28(2), 159-169
46. N HATANAKA, W KAMIKE, S SHIMIZU, M MIYATA, T INOUE, Y YOSHIDA, K TAGAWA and H MATSUDA (1995) ‘Ca2+ release from mitochondria induces cytosolic enzyme leakage in anoxic liver’. J Surg Res. 58(5), 485-490
47. A HAYASHI, AC GILLEN and JR LOTT (2000) ‘Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumor growth in Balb-c mice’. Altern Med Rev. 5(6), 546-552
48. E HERTERVIG, A NILSSON, L NYBERG and RD DUAN (1997) ‘Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma’. Cancer 79(3), 448-453
49. Y HIROMATSU, M SATO, K YAMADA and K NONAKA (1992) ‘Inhibitory effects of nicotinamide on recombinant human interferon-gamma-induced intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigen expression on cultured human endothelial cells’. Immunol Lett. 31(1), 35-39
50. B HOBSON and J DENEKAMP (1984) ‘Endothelial proliferation in tumours and normal tissues: continuous labeling studies’. Br. J. Cancer. 49(4), 405-413
51. S HODGES, N HERTZ, K LOCKWOOD and R LISTER (1999) ‘CoQ10: could it have a role in cancer management?’. Biofactors 9(2-4), 365-370
52. GF HU (1998) ‘Copper stimulates proliferation of human endothelial cells under culture’. J Cell Biochem. 69(3), 326-335
53. YT HUANG, JJ HWANG, PP LEE, FC KE, JH HUANG, CJ HUANG, C KANDASWAMI, JR MIDDLETONE and MT LEE (1999) ‘Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor’. Br J Pharmacol. 128(5), 999-1010
54. T IGARASHI, M ABE, M OIKAWA, T NUKIWA and Y SATO (2001) ‘Retinoic acids repress the expression of ETS-1 in endothelial cells’. Tohoku J Exp Med. 194(1), 35-43
55. MA IÑIGUEZ, A RODRÍGUEZ, OV VOLPERT, M FRESNO and JM REDONDO (2003) ‘Cyclooxygenase-2: a therapeutic target in angiogenesis’. Trends in Molec. Med. 9(2), 73-78
56. C IP, S BANNI, E ANGIONI, G CARTA, J McGINLEY, HJ THOMPSON, D BARBANO and D BAUMAN (1999) ‘Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats’. J Nutr. 129(12), 2135-2142
57. K ISEKI, M TATSUTA, H UEHARA, H IISHI, H YANO, N SAKAI and S ISHIGURO (1999) ‘Inhibition of angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats’. Int J Cancer. 81(5), 730-733
58. A IZZOTTI (2003) ‘DNA damage and alterations of gene expression in chronic-degenerative diseases’. Acta Biochim Pol. 50(1), 145-154
59. JR JACKSON, MP SEED, CH KIRCHER, DA WILLOUGHBY and JD WINKLER (1997) ‘The co-dependence of angiogenesis and chronic inflammation’. FASEB J. 11(6), 457-465
60. DC JAGGERS, WP COLLINS and SR MILLIGAN (1996) ‘Potent inhibitory effects of steroids in an in vitro model of angiogenesis’. J Endocrinol. 150(3), 457-464
61. SJ JAMES, L MUSKHELISHVILI, DW GAYLOR, A TURTURRO and R HART (1998) ‘Upregulation of apoptosis with dietary restriction: implications for carcinogenesis and aging’. Environ Health Perspect 106(Suppl 1), 307-312
62. D JARRETA, J ORUS, A BARRIENTOS, O MIRO, E ROIG, M HERAS, CT MORAES, F CARDELLACH and J CASADEMONT (2000) ‘Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy’. Cardiovasc Res. 45(4), 860-865
63. C JIANG, R AGARWAL and J LU (2000) ‘Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells’. Biochem Biophys Res Commun. 276(1), 371-378
64. C JIANG, W JIANG, C IP, H GANTHER and J LU (1999) ‘Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake’. Mol Carcinog 26(4), 213-225
65. M JOJOVIC, F WOLF and U MANGOLD (1998) ‘Epidermal growth factor, vascular endothelial growth factor and progesterone promote placental development in rat whole-embryo culture’. Anat Embryol (Berl) 198(2), 133-139
66. DP JONES (1995) ‘Mitochondrial dysfunction during anoxia and acute cell injury’. Biochim Biophys Acta. 1271(1), 29-33
67. AM JOUSSEN, K ROHRSCHNEIDER, J REICHLING, B KIRCHHOF and FE KRUSE (2000) ‘Treatment of corneal neovascularization with dietary isoflavonoids and flavonoids’. Exp Eye Res. 71(5), 483-487
68. T KANAYASU, I MORITA, J NAKAO-HAYASHI, N ASUWA, C FUJISAWA, T ISHII, H ITO and S MUROTA (1991) ‘Eicosapentaenoic acid inhibits tube formation of vascular endothelial cells in vitro’. Lipids 26(4), 271-276
69. JH KANG, KS KIM, SY CHOI, HY KWON, MH WON and TC KANG (2002) ‘Protective effects of carnosine, homocarnosine and anserine against peroxyl radical-mediated Cu, Zn-superoxide dismutase modification’. Biochim Biophys Acta. 1570(2), 89-96
70. AA KAPASI and PC SINGHAL (1999) ‘Aging splenocyte and thymocyte apoptosis is associated with enhanced expression of p53, bax, and caspase-3’. Mol Cell Biol Res Commun. 1(1), 78-81
71. AR KENNEDY (1998) ‘Chemopreventive agents: protease inhibitors’. Pharmacol Ther. 78(3), 167-209
72. M KESTER and R KOLESNICK (2003) ‘Sphingolipids as therapeutics’. Pharmacol Res. 47(5), 365-371
73. Y KIMURA, M TANIGUCHI and K BABA (2002) ‘Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance’. Anticancer Res. 22(6A), 3309-3318
74. AR KINI, LC PETERSON, MS TALLMAN and MW LINGEN (2001) ‘Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid’. Blood 97(12), 3919-3924
75. S. KOMATSU, N. YANAKA, K. MATSUBARA and N KATO (2003) ‘Antitumor effect of vitamin B6 and its mechanisms’. Biochimica et Biophysica Acta. 1647 127-130
76. HN KOO, HJ JEONG, SH HONG and JH CHOI (2002) ‘An NH, Kim HM. High molecular weight water-soluble chitosan protects against apoptosis induced by serum starvation in human astrocytes’. J Nutr Biochem. 13(4), 245-249
77. R KUMAR, J YONEDA, CD BUCANA and IJ FIDLER (1998) ‘Regulation of distinct steps of angiogenesis by different angiogenic molecules’. Int J Oncol. 12(4), 749-757
78. J LECOUTER, DR MORITZ, B LI, GL PHILLIPS, XH LIANG, HP GERBER, KJ HILLAN and N FERRARA (2003) ‘Angiogenesis-independent endothelial protection of liver: role of VEGFR-1’. Science 299(5608), 890-893
79. HC LEE and YH WEI (2001) ‘Mitochondrial alterations, cellular response to oxidative stress and defective degradation of proteins in aging’. Biogerontology 2(4), 231-244
80. G LENAZ, R FATO, C CASTELLUCCIO, M CAVAZZONI, E ESTORNELL, JF HUERTAS, F PALLOTTI, G PARENTI CASTELLI and H RAUCHOVA (1994) ‘An updating of the biochemical function of coenzyme Q in mitochondria’. Mol Aspects Med. s29-s36. 15 Suppl
81. G LENAZ, M D'AURELIO, PM MERLO, ML GENOVA, B VENTURA, C BOVINA, G FORMIGGINI and CG PARENTI (2000) ‘Mitochondrial bioenergetics in aging’. Biochim Biophys Acta. 1459(2-3), 397-404
82. D LI, JI WILLIAMS and RJ PIETRAS (2002) ‘Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression’. Oncogene 21(18), 2805-2814
83. Y LI, HY WANG and CH CHO (1999) ‘Association of heparin with basic fibroblast growth factor, epidermal growth factor, and constitutive nitric oxide synthase on healing of gastric ulcer in rats’. J Pharmacol Exp Ther. 290(2), 789-796
84. JH LIANG and KP WONG (2000) ‘The characterization of angiogenesis inhibitor from shark cartilage’. Adv Exp Med Biol. 476(1), 209-223
85. JF LIANG, L ZHEN, LC CHANG and V.C. YANG (2003) ‘A less toxic heparin antagonist-low molecular weight protamine’. Biochemistry (Mosc) 68(1), 116-120
86. JL LIESVELD, CN ABBOUD, C LU, C MCNAIR, A MENON, A SMITH, K ROSELL and AP RAPOPORT (2003) ‘Flavonoid effects on normal and leukemic cells’. Leuk Res. 27(6), 517-527
87. MT LIN, DK SIMON, CH AHN, LM KIM and MF BEAL (2002) ‘High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain’. Hum Mol Genet. 11(2), 133-145
88. AW LINNANE, S MARZUKI, T OZAWA and M TANAKA (1989) ‘Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases’. Lancet i 642-645
89. N LIU, RK LAPCEVICH, CB UNDERHILL, Z HAN, F GAO, G SWARTZ, SM PLUM, L ZHANG and SJ GREE (2001) ‘Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth’. Cancer Res. 61(3), 1022-1028
90. PG LLOYD, BM PRIOR, HT YANG and RL TERJUNG (2003) ‘Angiogenic growth factor expression in rat skeletal muscle in response to exercise training’. Am J Physiol Heart Circ Physiol. 284(5), H1668-H1678
91. J.N. LOSSO (2002) ‘Preventing Degenerative Diseases by Anti-Angiogeneic Functional Foods’. Food Technol. 56 78-88
92. J.N. LOSSO (2003) ‘Targeting excessive angiogenesis with functional foods and nutraceuticals’. Trends Food Sci Technol. 14(11), 455-468
93. J LU and C JIANG (2001) ‘Antiangiogenic activity of selenium in cancer chemoprevention: metabolite-specific effects’. Nutr Cancer. 40(1), 64-73
94. WK LUTZ and J SCHLATTER (1992) ‘Chemical carcinogens and overnutrition in diet-related cancer’. Carcinogenesis 13(12), 2211-2216
95. L MA, JY CHOW, BC WONG and CH CHO (2000) ‘Role of capsaicin sensory nerves and EGF in the healing of gastric ulcer in rats’. Life Sci. 66(15), PL213-PL220
96. AJ MACARIO and E CONWAY DE MACARIO (2000) ‘Stress and molecular chaperones in disease’. Int J Clin Lab Res. 30(2), 49-66
97. S MAJEWSKI, M SKOPINSKA, M MARCZAK, A SZMURLO, W BOLLAG and S JABLONSKA (1996) ‘Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis’. J Investig Dermatol Symp Proc. 1(1), 97-101
98. MP MALAFA, FD FOKUM, L SMITH and A LOUIS (2002) ‘Inhibition of angiogenesis and promotion of melanoma dormancy by vitamin E succinate’. Ann Surg Oncol. 9(10), 1023-1032
99. EV MALYKH and NI LARIONOVA (2002) ‘Study of antiproteinase activity of acylated derivatives of Bowman-Birk soybean proteinase inhibitor’. Biochemistry (Mosc) 67(12), 1383-1387
100. BS MANDAVILLI, JH SANTOS and B VAN HOUTEN (2002) ‘Mitochondrial DNA repair and aging’. Mutat Res. 509(1-2), 127-151
101. PA MASSO-WELCH, D ZANGANI, C IP, MM VAUGHAN, S SHOEMAKER, RA RAMIREZ and MM IP (2002) ‘Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid’. Cancer Res. 62(15), 4383-4389
102. PH MAXWELL (2002) ‘Oxygen homeostasis and cancer: insights from a rare disease’. Clin Med. 2(4), 356-362
103. MF MCCARTY (2003) ‘A wholly nutritional ‘multifocal angiostatic therapy’ for control of disseminated cancer’. Med Hypotheses 61(1), 1-15
104. S MELOV, P COSKUN, M PATEL, R TUINSTRA, B COTTRELL, AS JUN, TH ZASTAWNY, M DIZDAROGLU, SI GOODMAN, TT HUANG, H MIZIORKO, CJ EPSTEIN and DC WALLACE (1999) ‘Mitochondrial disease in superoxide dismutase 2 mutant mice’. Proc Natl Acad Sci USA. 96(3), 846-851
105. M MEYDANI (2002) ‘The Boyd Orr lecture. Nutrition interventions in aging and age-associated disease’. Proc Nutr Soc. 61(2), 165-171
106. J MEYNE, RL RATLIFF and RK MOYSIS (1989) ‘Conservation of the human telomere sequence (TTAGGG)n among vertebrates’. Proc. Natl Acad. Sci. USA. 86(18), 7049-7053
107. J MIQUEL (2001) ‘Nutrition and ageing’. Public Health Nutr. 4(6A), 1385-1388
108. M MOENNER, M CHAUVIERE, P CHEVAILLIER and J BADET (1999) ‘Basic homopolyamino acids, histones and protamines are potent antagonists of angiogenin binding to ribonuclease inhibitor’. FEBS Lett. 443(3), 303-307
109. BS MANDAVILLI, JH SANTOS and B VAN HOUTEN (2002) ‘Mitochondrial DNA repair and aging’. Mutat Res. 509(1-2), 127-151
110. R MOHAN, J SIVAK, P ASHTON, LA RUSSO, BQ PHAM, N KASAHARA and MB RAIZMAN FINI (2000) ‘Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B’. J Biol Chem. 275(14), 10405-10412
111. M MORIMURA, O ISHIKO, T SUMI, H YOSHIDA and S OGITA (2001) ‘Angiogenesis in adipose tissues and skeletal muscles with rebound weight-gain after diet-restriction in rabbits’. Int J Mol Med. 8(5), 499-503
112. H MOTEKI, H HIBASAMI, Y YAMADA, H KATSUZAKI, K IMAI and T KOMIYA (2002) ‘Specific induction of apoptosis by 1,8-cineole in two human leukemia cell lines, but not a in human stomach cancer cell line’. Oncol Rep. 9(4), 757-760
113. P MUKHERJEE, MM EL-ABBADI, JL KASPERZYK, MK RANES and TN SEYFRIED (2002) ‘Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model’. Br J Cancer. 86(10), 1615-1621
114. T MUROHARA, H IKEDA, A KATOH, Y TAKAJO, Y OTSUKA, N HARAMAKI and T IMAIZUMI (2002) ‘Vitamin E inhibits lysophosphatidylcholine-induced endothelial dysfunction and platelet activation’. Antioxid Redox Signal. 4(5), 791-798
115. RA MUZZARELLI, M MATTIOLI-BELMONTE, A PUGNALONI and G BIAGINI (1999) ‘Biochemistry, histology and clinical uses of chitins and chitosans in wound healing’. EXS 87 251-264
116. C NUCCI, L MORRONE, L ROMBOLA, R NISTICO, S PICCIRILLI and L CERULLI (2003) ‘Multifaceted roles of nitric oxide in the lateral geniculate nucleus: from visual signal trans- duction to neuronal apoptosis’. Toxicol Lett. 139(2-3), 163-173
117. N OBANA, S TAKAGI, Y KINOUCHI, Y TOKITA, A SEKIKAWA, S TAKAHASHI, N HIWATASHI, S OIKAWA and T SHIMOSEGAWA (2003) ‘Telomere shortening of peripheral blood mononuclear cells in coronary disease patients with metabolic disorders’. Intern Med. 42(2), 150-153
118. Y OKAMOTO, K SHIBAZAKI, S MINAMI, A MATSUHASHI, S TANIOKA and Y SHIGEMASA (1995) ‘Evaluation of chitin and chitosan on open wound healing in dogs’. J. Vet. Med. Sci. 57(5), 851-854
119. T OZAWA (1999) ‘Mitochondrial genome mutation in cell death and aging’. J Bioenerg Biomembr. 31(4), 377-390
120. M PAPETTI and IM HERMAN (2002) ‘Mechanisms of normal and tumor-derived angiogenesis’. Am. J. Physiol Cell Physiol. 282(5), C947-C970
121. PA PARONE, D JAMES and JC MARTINOU (2002) ‘Mitochondria: regulating the inevitable’. Biochimie. 84(2-3), 105-111
122. R PASQUALINI, W ARAP and DM MCDONALD (2002) ‘Probing the structural and molecular diversity of tumor vasculature’. Trends Mol Med. 8(12), 563-571
123. C PELLIZZARO, D CORADINI and MG DAIDONE (2002) ‘Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29’. Carcinogenesis 23(5), 735-740
124. EA PLATZ (2002) ‘Energy imbalance and prostate cancer’. J Nutr. 132(11 Suppl), 3471S-3481S
125. M POLETTE, E HUET, P BIREMBAUT, FX MAQUART, W HORNEBECK and H EMONARD (1999) ‘Influence of oleic acid on the expression, activation and activity of gelatinase A produced by oncogene-transformed human bronchial epithelial cells’. Int J Cancer. 80(5), 751-755
126. M POLLARD (1999) ‘Prevention of prostate-related cancers in Lobund-Wistar rats’. The Prostate 39 305-309
127. AF QUIGLEY, RM KAPSA, D ESMORE, G HALE and E BYRNE (2000) ‘Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy’. J Card Fail. 6(1), 47-55
128. NS RADIN (2003) ‘Killing tumours by ceramide-induced apoptosis: a critique of available drugs’. Biochem J. 371(2), 243-256
129. CV RAO, B SIMI and BS REDDY (1993) ‘Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon’. Carcinogenesis 14(11), 2219-2225
130. READ CALNA (2000) ‘Mitochondria disease: Beyond etiology unknown’. J. Pediatric Nursing. 15(4), 232-241
131. RJ RUCH and K SIGLER (1994) ‘Growth inhibition of rat liver epithelial tumor cells by monoterpenes does not involve Ras plasma membrane association’. Carcinogenesis 15(4), 787-789
132. B SANO, Y SUGIYAMA, K KUNIEDA, J SANO and S SAJI (2002) ‘Antitumor effects induced by the combination of TNP-470 as an angiogenesis inhibitor and lentinan as a biological response modifier in a rabbit spontaneous liver metastasis model’. Surg Today. 32(6), 503-509
133. H SASAMURA, A TAKAHASHI, N MIYAO, M YANASE, N MASUMORI, H KITAMURA, N ITOH and T TSUKAMOTO (2002) ‘Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma’. Br J Cancer. 86(5), 768-773
134. J SASTRE, FV PALLARDO and J VINA (2000) ‘Mitochondrial oxidative stress plays a key role in aging and apoptosis’. IUBMB Life. 49(5), 427-435
135. H SAWA, H MURAKAMI, Y OHSHIMA, M MURAKAMI, I YAMAZAKI, Y TAMURA, T MIMA, A SATONE, W IDE, I HASHIMOTO and H KAMADA (2002) ‘Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF), secretion from human glioblastoma cells’. Brain Tumor Pathol. 19(2), 77-81
136. M SAWADA, S NAKASHIMA, Y BANNO, H YAMAKAWA, K HAYASHI, K TAKENAKA, Y NISHIMURA, N SAKAI and Y NOZAWA (2000) ‘Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells’. Cell Death Differ. 7 761-772
137. FA SCAPPATICCI (2002) ‘Mechanisms and future directions for angiogenesis-based cancer therapies’. J. Clin. Oncol. 20(18), 3906-3927
138. K SCHARFFETTER-KOCHANEK, M WLASCHEK, P BRENNEISEN, M SCHAUEN, R BLAUDSCHUN and J. WENK (1997) ‘UV-induced reactive oxygen species in photocarcinogenesis and photoaging’. Biol Chem. 378(11), 1247-1257
139. H SCHILEPHAKE (2002) ‘Bone growth factors in maxillofacial skeletal reconstruction’. Int J Oral Maxillofac Surg. 31(5), 469-484
140. EM SCHMELZ, MC SULLARDS, DL DILLEHAY and AH MERRILL JR. (2000) ‘Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice’. J Nutr. 130(3), 522-527
141. E SHACTER and SA WEITZMAN (2002) ‘Chronic inflammation and cancer’. Oncology 16(2), 217-232
142. ZM SHAO, ZZ SHEN, CH LIU, MR SARTIPPOUR, VL GO, D HEBER and M NGUYEN (2002) ‘Curcumin exerts multiple suppressive effects on human breast carcinoma cells’. Int J Cancer. 98(2), 234-240
143. S SHARMA, M GHODDOUSSI, P GAO, GJ KELLOFF, VE STEELE and L KOPELOVICH (2001) ‘A quantitative angiogenesis model for efficacy testing of chemopreventive agents’. Anticancer Res. 21(6A), 3829-3837
144. XR SHEN, DM JI, FX JIA, XX DENG, JH SUN, XR HU and DM REN (2001) ‘Purification and Functional Characterization of a Shark Cartilage Factor Inhibitory to Angiogenesis’. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 32(1), 43-48
145. S SHIBATA (2001) ‘Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds’. J. Korean Med. Sci. 16 S28-S37. (Suppl)
146. M SHIMAMURA, T HAZATO, H ASHINO, Y YAMAMOTO, E IWASAKI, H TOBE, K YAMAMOTO and S YAMAMOTO (2001) ‘Inhibition of angiogenesis by humulone, a bitter acid from beer hop’. Biochem Biophys Res Commun. 289(1), 220-224
147. I SHIMOKAWA, Y HIGAMI, T TSUCHIYA, H OTANI, T KOMATSU, T CHIBA and H YAMAZA (2003) ‘Life span extension by reduction of the growth hormone-insulin-like growth factor-1 axis: relation to caloric restriction’. FASEB J. 17(9), 1108-1109
148. MT SHOKRAVI, DM MARCUS, J ALROY, K EGAN, MA SAORNIL and DM ALBERT (1995) ‘Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma’. Invest Ophthalmol Vis Sci. 36(1), 83-87
149. Y SHUKLA, A ARORA and A SINGH (2002) ‘Antitumorigenic potential of diallyl sulfide in Ehrlich ascites tumor bearing mice’. Biomed Environ Sci. 15(1), 41-47
150. CW SHULTS, D OAKES, K KIEBURTZ, M BEAL, R HAAS, S PLUMB, JL JUNCOS, J NUTT, I SHOULSON, J CARTER, K KOMPOLITI, JS PERLMUTTER, S REICH, M STERN, RL WATTS, R KURLAN, E MOLHO, M HARRISON and M LEW (2002) ‘Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline’. Arch Neurol. 59(10), 1523. PARKINSON STUDY GROUP
151. RK SINGHAL and A JAIN (2000) ‘Glutathione ethyl ester supplementation prevents mortality in newborn rats exposed to hyperoxia’. Biol Neonate. 77(4), 261-266
152. RS SOHAL and R WEINDRUCH (1996) ‘Oxidative stress, caloric restriction, and aging’. Science 273(5271), 59-63
153. S SOKER, CM SVAHN and G NEUFELD (1993) ‘Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin’. J Biol Chem. 268(11), 7685-7691
154. YS SONG, EH PARK, KJ JUNG and C JIN (2002) ‘Inhibition of angiogenesis by propolis’. Arch Pharm Res. 25(4), 500-504
155. S SPIEGEL and AH MERRILL JR (1996) ‘Sphingolipid metabolism and cell growth regulation’. FASEB J. 10(12), 1388-1397
156. R SRIDHAR, O HANSON-PAINTON and DR COOPER (2000) ‘Protein kinases as therapeutic targets’. Pharm Res. 17(11), 1345-1353
157. L STRAUSS, M FUENZALIDA, J ILLANES, A DABANCENS, E DIAZ, D LEMUS and A GUERRERO (2002) ‘Effect of sulfated beta-cyclodextrin, a water soluble cycloamylose, on the promotion and/or inhibition of angiogenesis’. Pathol Oncol Res. 8(1), 47-53
158. SG SUNDARAM and JA MILNER (1996) ‘Diallyl disulfide inhibits the proliferation of human tumor cells in culture’. Biochim Biophys Acta. 1315(1), 15-20
159. YJ SUHR (2002) ‘Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review’. Food Chem Toxicol. 40(8), 1091-1097
160. YJ SUHR, RC LEE, KK PARK, ST MAYNE, A LIEM and JA MILLER (1995) ‘Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine’. Carcinogenesis 16(10), 2467-2471
161. CJ SWEENEY, KD MILLER and GW SLEDGE JR. (2003) ‘Resistance in the anti-angiogenic era: nay-saying or a word of caution?’. Trends Mol Med. 9(1), 24-29
162. T TAKAKU, Y KIMURA and H OKUDA (2001) ‘Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action’. J Nutr. 131(5), 1409-1413
163. BA TEICHER, JI WILLIAMS, H TAKEUCHI, G ARA, RS HERBST and D BUXTON (1998) ‘Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma’. Anticancer Res. 18(4A), 2567-2573
164. C SZABÓ and H OHSHIMA (1997) ‘DNA damage induced by peroxynitrite: subsequent biological effects’. Nitric Oxide. 1(5), 373-385
165. C TEMPEL, A GILEAD and M NEEMAN (2000) ‘Hyaluronic acid as an anti-angiogenic shield in the preovulatory rat follicle’. Biol Reprod. 63(1), 134-140
166. E THAM, J WANG, F PIEHL and G WEBER (2002) ‘Upregulation of VEGF-A without angiogenesis in a mouse model of dilated cardiomyopathy caused by mitochondrial dysfunction’. J Histochem Cytochem. 50(7), 935-944
167. CB THOMPSON (1995) ‘Apoptosis in the pathogenesis and treatment of disease’. Science 267(XX), 1456-1462
168. H UENO, H YAMADA, I TANAKA, N KABA, M MATSUURA, M OKUMURA, T KADOSAWA and T FUJINAGA (1999) ‘Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs’. Biomaterials 20(15), 1407-1414
169. M URAO, G UEDA, M ABE, K KANNO, S HIROSE and T SHIRAI (1995) ‘Food restriction inhibits an autoimmune disease resembling systemic lupus erythematosus in (NZB x NZW) F1 mice’. J Nutr. 125(9), 2316-2324
170. H VESPER, EM SCHMELZ, MN NIKOLOVA-KARAKASHIAN, DL DILLEHAY, DV LYNCH and AH MERRILL JR. (1999) ‘Sphingolipids in food and the emerging importance of sphingolipids to nutrition’. J Nutr. 129(7), 1239-1250
171. I VLODAVSKY, M ELKIN, O PAPPO, H AINGORN, R ATZMON, R ISHAI-MICHAELI, A AVIV, I PECKER and Y FRIEDMANN (2000) ‘Mammalian heparanase as mediator of tumor metastasis and angiogenesis’. Isr Med Assoc J. 2 37-45. (Suppl)
172. PD WAGNER (2001) ‘Skeletal muscle angiogenesis. A possible role for hypoxia’. Adv Exp Med Biol. 502(1), 21-38
173. DC WALLACE (2000) ‘Mitochondrial defects in cardiomyopathy and neuromuscular disease’. Am Heart J. 139(2 Pt 3), S70-S85
174. DC WALLACE, M SHOFFNER, I TROUNCE, MD BROWN, SW BALLINGER, M CORRAL-DEBRINSKI, T HORTON, AS JUN and MT LOTT (1995) ‘Mitochondrial DNA mutations in human degenerative diseases and aging’. Biochim Biophys Acta. 1271(1), 141-151
175. YH WEI (1998) ‘Oxidative stress and mitochondrial DNA mutations in human aging’. Proc Soc Exp Biol Med. 217(1), 53-63
176. YH WEI and HC LEE (2002) ‘Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging’. Exp Biol Med (Maywood) 227(9), 671-682
177. N WERNERT, A STANJEK, S KIRIAKIDIS, A HUGEL, HC JHA, R MAZITSCHEK and A GIANNIS (1999) ‘Inhibition of Angiogenesis In Vivo by ets-1 Antisense Oligonucleotides-Inhibition of Ets-1 Transcription Factor Expression by the Antibiotic Fumagillin’. Angew Chem Int Ed Engl. 38(21), 3228-3231
178. BG WOUTERS, SA WEPPLER, M KORITZINSKY, W LANDUYT, S NUYTS, J THEYS, RK CHIU and P LAMBIN (2002) ‘Hypoxia as a target for combined modality treatments’. Eur J Cancer. 38(2), 240-257
179. F YIN, AE GIULIANO and AJ VAN HERLE (1999) ‘Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO)’. Anticancer Res. 19(5B), 4297-4303
180. F YIN, AE GIULIANO and AJ VAN HERLE (1999) ‘Growth inhibitory effects of flavonoids in human thyroid cancer cell lines’. Thyroid 9(4), 369-376
181. M YONEDA, K KATSUMATA, M HAYAKAWA, M TANAKA and T OZAWA (1995) ‘Oxygen stress induces an apoptotic cell death associated with fragmentation of mitochondrial genome’. Biochem Biophys Res Commun. 209(2), 723-729
182. D ZGOURAS, A WACHTERSHAUSER, D FRINGS and J STEIN (2003) ‘Butyrate impairs intestinal tumor cell-induced angiogenesis by inhibiting HIF-1alpha nuclear translocation’. Biochem Biophys Res Commun. 300(4), 832-838
183. JR ZHOU, P MUKHERJEE, ET GUGGER, T TANAKA, GL BLACKBURN and SK CLINTON (1998) ‘Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis’. Cancer Res. 58 5231-5238